
Twist Bioscience rose 323.3% from $26.46 to $112.00, ahead of the S&P 500's +10.0%. Its worst day was Oct 6 (−18.6%), and its low came Nov 19 at $25.45.
Nov 17, 2025 – Nov 17, 2026 · picked from earnings, analyst actions, headlines and the biggest daily moves
Twist Bioscience closed at its lowest level of the year, 3.8% below where the year started.
−2.1% · S&P 500 +0.4%
EPS of $-0.50 beat the $-0.50 estimate on $103.7M revenue (est. $102.7M); Q2 revenue guidance of $107.0M–$108.0M against the $104.5M consensus.
Story events cover the past 12 months · Times ET
+14.0% · S&P 500 +0.5%
Twist Bioscience shares rose 14.0%, while the S&P 500 rose 1.2%.
+14.0% · S&P 500 +1.2%
EPS of $-0.59 missed the $-0.53 estimate on $110.7M revenue (est. $107.7M); FY revenue guidance of $442.0M–$447.0M against the $438.8M consensus.
−7.0% · S&P 500 −0.4%
EPS of $-0.56 missed the $-0.24 estimate on $118.4M revenue (est. $114.5M); FY revenue guidance of $456.0M–$457.0M against the $446.5M consensus.
+10.4% · S&P 500 +1.4%
Twist Bioscience (TWST) stock jumped 17% after Anthropic chose the firm to test AI-designed proteins.
+22.6%, the year's best day · S&P 500 +0.2%
Twist Bioscience shares rose 16.1%, while the S&P 500 fell 0.1%.
+16.1% · S&P 500 −0.1%
Twist Bioscience closed at its highest level of the year, 674.8% above where the year started.
+8.7% · S&P 500 +0.7%
Twist Bioscience shares fell 15.5%, while the S&P 500 fell 0.5%.
−15.5% · S&P 500 −0.5%
EPS of $-0.32 missed the $-0.25 estimate on $126.6M revenue (est. $123.6M); FY revenue guidance of $550.0M–$560.0M against the $549.0M consensus.
−6.8% · S&P 500 −0.4%
Where it ended: a close of $112.00 on Nov 17, 2026. Up next: Q1 2027 earnings on Feb 1, 2027 (EPS est. $-0.20, revenue est. $129.9M).
Nothing in the past 12 months.
All TWST dividend historyReplay the year: the line draws itself and stops at each of the 10 moments with what happened and how the stock reacted.
Chart by ChartIQ. Events, ratings, quote and fundamentals from Benzinga APIs. Daily bars for TWST and SPY from Benzinga historical bars. Not investment advice.